Picture of HLS Therapeutics logo

HLS HLS Therapeutics News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Brief: Hls Therapeutics Announces Q1 Fiscal 2023 Financial Results

May 11 (Reuters) - Hls Therapeutics Inc  HLS.TO :
    * HLS THERAPEUTICS ANNOUNCES Q1 FISCAL 2023 FINANCIAL
RESULTS
    * APPOINTED CRAIG MILLIAN AS CHIEF EXECUTIVE OFFICER OF
COMPANY
    * Q1 2023 REVENUE WAS $14.8 MILLION COMPARED TO $14.6
MILLION
    * NET LOSS FOR Q1 2023 WAS ($0.18) PER SHARE

Source text for Eikon:  ID:nCNWlRYqpa 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on HLS Therapeutics

See all news